JP2012500261A - 疲労した対象のためのｄ−リボースの使用 - Google Patents

疲労した対象のためのｄ−リボースの使用 Download PDF

Info

Publication number
JP2012500261A
JP2012500261A JP2011523814A JP2011523814A JP2012500261A JP 2012500261 A JP2012500261 A JP 2012500261A JP 2011523814 A JP2011523814 A JP 2011523814A JP 2011523814 A JP2011523814 A JP 2011523814A JP 2012500261 A JP2012500261 A JP 2012500261A
Authority
JP
Japan
Prior art keywords
ribose
fatigue
effective amount
subjects
grams
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011523814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012500261A5 (fr
Inventor
シル，ジョン エー． セント
ジェイ． マッカーター，ディーン
Original Assignee
バイオエナジー インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオエナジー インコーポレイティド filed Critical バイオエナジー インコーポレイティド
Publication of JP2012500261A publication Critical patent/JP2012500261A/ja
Publication of JP2012500261A5 publication Critical patent/JP2012500261A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physiology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2011523814A 2008-08-20 2009-08-20 疲労した対象のためのｄ−リボースの使用 Withdrawn JP2012500261A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18949808P 2008-08-20 2008-08-20
US61/189,498 2008-08-20
US20812209P 2009-02-20 2009-02-20
US61/208,122 2009-02-20
PCT/US2009/004738 WO2010021713A1 (fr) 2008-08-20 2009-08-20 Utilisation de d-ribose pour des sujets fatigués

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015095225A Division JP2016014009A (ja) 2008-08-20 2015-05-07 疲労した対象のためのｄ−リボースの使用

Publications (2)

Publication Number Publication Date
JP2012500261A true JP2012500261A (ja) 2012-01-05
JP2012500261A5 JP2012500261A5 (fr) 2012-10-04

Family

ID=41172394

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011523814A Withdrawn JP2012500261A (ja) 2008-08-20 2009-08-20 疲労した対象のためのｄ−リボースの使用
JP2015095225A Pending JP2016014009A (ja) 2008-08-20 2015-05-07 疲労した対象のためのｄ−リボースの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015095225A Pending JP2016014009A (ja) 2008-08-20 2015-05-07 疲労した対象のためのｄ−リボースの使用

Country Status (8)

Country Link
US (2) US20100189785A1 (fr)
EP (1) EP2323668A1 (fr)
JP (2) JP2012500261A (fr)
CN (2) CN105232564A (fr)
AU (1) AU2009283215B2 (fr)
BR (1) BRPI0917360A2 (fr)
CA (1) CA2734769A1 (fr)
WO (1) WO2010021713A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2413942A1 (fr) * 2008-04-02 2012-02-08 Bioenergy Inc. Utilisation de ribose lors d une première intervention en cas d infarctus aigu du myocarde
CN102488669A (zh) * 2011-12-30 2012-06-13 上海希迪制药有限公司 一种改善d-核糖引湿性的方法
RU2746128C2 (ru) * 2014-11-03 2021-04-07 Байоэнерджи Лайф Сайенс, Инк. Применение d-рибозы для усиления процесса адаптации к физическому стрессу
WO2017120731A1 (fr) * 2016-01-11 2017-07-20 Shanghai Yao Yuan Biotechnology Co., Ltd. Méthodes et compositions pour réduire la masse corporelle
JP6542687B2 (ja) 2016-01-28 2019-07-10 日本特殊陶業株式会社 ガスセンサユニット
US10434113B2 (en) 2016-12-16 2019-10-08 The Charlotte Mecklenburg Hospital Authority Compositions and methods for treating muscular dystrophy and other disorders
WO2019200132A1 (fr) * 2018-04-12 2019-10-17 Metabolic Recovery Systems, LLC Compositions et procédés pour compléter le régime alimentaire
WO2020041750A1 (fr) * 2018-08-24 2020-02-27 The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health Méthodes et compositions de traitement de troubles associés à une faiblesse musculaire
KR102435548B1 (ko) * 2022-05-31 2022-08-26 (주)에이피테크놀로지 액상스틱형 에너지 스포츠 음료

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002518321A (ja) * 1998-06-19 2002-06-25 バイオエナジー インコーポレイティド エネルギーをインビボで増加させるための組成物
JP2003516315A (ja) * 1999-09-24 2003-05-13 バイオエナジー インコーポレイティド 筋肉の痙攣及び筋肉痛を予防するためのリボースの利用
JP2007529409A (ja) * 2004-03-18 2007-10-25 田辺製薬株式会社 うつ様症状改善剤
WO2008076296A2 (fr) * 2006-12-15 2008-06-26 Bioenergy, Inc. Méthode améliorant la fonction de ventilation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228215A1 (de) * 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
EP1745789A1 (fr) * 1998-06-19 2007-01-24 Bioenergy Inc. Compositions contenants ribose pour élever l'energie in vivo
EP1095658A3 (fr) * 1999-10-27 2002-10-23 Bioenergy Inc. Utilisation du ribose dans le traitement de la fibromyalgie
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
US6855727B2 (en) * 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
EP1786436B1 (fr) * 2004-04-29 2012-11-14 RiboCor, Inc. Procede pour ameliorer l'efficacite ventilatoire
US7645742B2 (en) * 2005-06-22 2010-01-12 Advocare International, L.P. Composition for enhancing cellular energy
WO2022123637A1 (fr) 2020-12-07 2022-06-16 株式会社日立製作所 Système de traitement de document et procédé de traitement de document

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002518321A (ja) * 1998-06-19 2002-06-25 バイオエナジー インコーポレイティド エネルギーをインビボで増加させるための組成物
JP2003516315A (ja) * 1999-09-24 2003-05-13 バイオエナジー インコーポレイティド 筋肉の痙攣及び筋肉痛を予防するためのリボースの利用
JP2007529409A (ja) * 2004-03-18 2007-10-25 田辺製薬株式会社 うつ様症状改善剤
WO2008076296A2 (fr) * 2006-12-15 2008-06-26 Bioenergy, Inc. Méthode améliorant la fonction de ventilation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6013056564; Ｔｈｅ　Ｊｏｕｒｎａｌ　ｏｆ　Ａｌｔｅｒｎａｔｉｖｅ　ａｎｄ　Ｃｏｍｐｌｅｍｅｎｔａｒｙ　Ｍｅｄｉｃｉｎｅ Ｖｏｌ．１２, 2006, ｐ．８５７-８６２ *

Also Published As

Publication number Publication date
US20120264701A1 (en) 2012-10-18
JP2016014009A (ja) 2016-01-28
CA2734769A1 (fr) 2010-02-25
US20100189785A1 (en) 2010-07-29
AU2009283215A2 (en) 2011-05-12
AU2009283215A1 (en) 2010-02-25
EP2323668A1 (fr) 2011-05-25
CN102215846A (zh) 2011-10-12
BRPI0917360A2 (pt) 2015-11-17
WO2010021713A1 (fr) 2010-02-25
CN105232564A (zh) 2016-01-13
AU2009283215B2 (en) 2014-12-04

Similar Documents

Publication Publication Date Title
JP2016014009A (ja) 疲労した対象のためのｄ−リボースの使用
EP1087779B1 (fr) Compositions permettant d'accroitre l'energie in vivo
KR100878133B1 (ko) 탄수화물 및 전해질 보충 조성물
CN102448452A (zh) 用于支持糖尿病治疗的包含α-酮酸的膳食补充剂
JPWO2013054525A1 (ja) システインペプチド含有健康飲料
Flores et al. Shorter sprints elicit greater cardiorespiratory and mechanical responses with less fatigue during time-matched sprint interval training (SIT) sessions
Sekine et al. The impact of sleep deprivation on the coronary circulation
Remchak et al. Exercise blood pressure and heart rate responses to graded exercise testing in intermediate versus morning chronotypes with obesity
EP3135273B1 (fr) Compositions de matieres minerales destinees a amorcer le metabolisme glucidique
Mengelkoch et al. Effects of Age, Physical Training, and Physical Fitness on Coronary Heart Disease Risk Factors in Older Track Athletes at Twenty‐Year Follow‐up
WO2014155186A1 (fr) Complément alimentaire pour personnes souffrant de trisomie 21, de trouble du spectre autiste et/ou de trouble du déficit de l'attention avec ou sans hyperactivité
US20160317561A1 (en) Use of d-ribose for fatigued subjects
Shi Cardiac structure and function in young athletes
Paulev Exercise and risk factors for arteriosclerosis in 42 married couples followed over four years
CN101264093B (zh) 用于增加体内能量的组合物
EP1745789A1 (fr) Compositions contenants ribose pour élever l'energie in vivo
US20240075000A1 (en) Treatment of pathological fatigue with oxaloacetate
Kirkpatrick Effects of active versus passive recovery on blood lactate and performance in repeated Wingate tests
Alis The effects of a coconut beverage on blood glucose and lactate concentrations
Ištvanović et al. Influence of in-hospital cardiac rehabilitation on psychological status after myocardial infarction in patients with D-type personality
Szabóová et al. Can the Regular Physical Load Change the Functional State of Pupils in Elementary School?
Rahimi Quantification of the anaerobic contribution during low to moderate intensity exercise with different fluctuation amplitudes
Sinatra et al. Enhancing cardiac energy with ribose
Derosier The effects of varying postexercise nutrition on subsequent exercise performance in active adults habitually consuming a low-carbohydrate/high-fat diet
Roxburgh The effect of continuous moderate intensity exercise training combined with high intensity interval training on cardiovascular disease risk factors

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120820

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120820

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140218

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140225

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140519

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150106

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20150507

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20151016